Common Fungi. Catherine Diamond MD MPH

Similar documents
Fungal infection in the immunocompromised patient. Dr Kirsty Dodgson

Management of fungal infection

Case Studies in Fungal Infections and Antifungal Therapy

Fungal update. Liise-anne Pirofski, M.D. Albert Einstein College of Medicine

ECMM Excellence Centers Quality Audit

Fungal biology. Fungal Infections. Fungal cell structure. Pathogenesis

Fungal biology. Pathogenesis. Fungal cell structure. Fungal Infections MID 25 & 26. Eukaryotic (organized nucleus and cell structure) Non-motile

Use of Antifungals in the Year 2008

Fungal Infection Post-Infusion Data

Use of Antifungal Drugs in the Year 2006"

MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS

Fungal Infection Pre-Infusion Data

Antifungal drugs Dr. Raz Muhammed

Fungal Infections. Fungal Infections

Condition First line Alternative Comments Candidemia Nonneutropenic adults

Introduction. Study of fungi called mycology.

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell

Pulmonary Infections: Fungus. Part I: Background Information and Dimorphic Fungus. Part II: Opportunistic Yeast and Molds

Prophylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases. Y.L. Kwong Department of Medicine University of Hong Kong

Mycology Reference Centre, Leeds Information for Service Users 2017

Fungal Meningitis. Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse Bern

Antifungal therapies differences in agents

ADEQUATE ANTIFUNGAL USE FOR BLOODSTREAM INFECTIONS

Fungal Infections: Reporting. Marcie Tomblyn, MD, MS Associate Member, Moffitt Cancer Center

Case 1. Background. Presenting Symptoms. Schecter Case1 Differential Diagnosis of TB 1

PAGL Inclusion Approved at January 2017 PGC

HAEMATOLOGY ANTIFUNGAL POLICY

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy:

Antifungal Update 2/22/12. Which is the most appropriate initial empirical therapy in a candidemic patient?

2046: Fungal Infection Pre-Infusion Data

Case. Fungal infections for the community provider. Case. Case. April 25, 2014 Peter V. Chin-Hong M.D. Infectious Diseases UCSF UCSF

Fungal Infections. Alessandro Diana November 22th 2007

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens

Antifungal Update. Candida: In Vitro Antifungal Susceptibility Testing

Cigna Drug and Biologic Coverage Policy

Neutropenic Fever. CID 2011; 52 (4):e56-e93

How to make a fast diagnosis

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia

TOWARDS PRE-EMPTIVE? TRADITIONAL DIAGNOSIS. GALACTOMANNAN Sensitivity 61% Specificity 93% Neg Predict Value >95% β-d-glucan Neg Predict Value 100% PCR

Improving Clinical Outcomes in Fungal Infection Control and Management

Ali Alabbadi. Sarah Jaar ... Nader

General History. 林陳 珠 Female 69 years old 住院期間 : ~ Chief Complaint : sudden loss of conscious 5 minutes in the morning.

Antifungal Update 2/24/11. Which is the most appropriate initial empirical therapy in a candidemic patient?

Voriconazole October 2015 Risk Management Plan. Voriconazole

Invasive Fungal Infections in Solid Organ Transplant Recipients

Current Options in Antifungal Pharmacotherapy

CURRENT AND NEWER ANTI-FUNGAL THERAPIES- MECHANISMS, INDICATIONS, LIMITATIONS AND PROBLEMS. Dr AMIT RAODEO DM SEMINAR

North American Endemic Fungi

number Done by Corrected by Doctor

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Dr Kaniz Fatema. FCPS (Medicine), MD (Critical Care Medicine) Associate Professor Dept of Critical Care Medicine BIRDEM General Hospital

Antifungals and current treatment guidelines in pediatrics and neonatology

PROGRESSI NELLA TERAPIA ANTIFUNGINA. A tribute to Piero Martino

Fungal Infections in Neutropenic Hematological Disorders

Antifungal Agents - Cresemba (isavuconazonium), Vfend. Prior Authorization Program Summary

Approach to Fungal Infections

Cryptococcal Meningitis

Introduction Medical Mycology. Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan

Epidemiology and ecology of fungal diseases

About the Editor Gerri S. Hall, Ph.D.

Mycobacteria and fungal infections of the respiratory tract

Aspergillus species. The clinical spectrum of pulmonary aspergillosis

Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance 13

ESCMID Online Lecture Library. by author. CASE PRESENTATION ECCMID clinical grand round May Anat Stern, MD Rambam medical center Haifa, Israel

Fungal infections and critically ill adults

Current and Emerging Azole Antifungal Agents

New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance

Management Strategies For Invasive Mycoses: An MD Anderson Perspective

8/2/10. Sanaz Jalali, Jennifer Demler, Jeremy King. Histoplasmosis is an intracellular mycotic infection of the reticuloendothelial system.

Antifungal Resistance in Asia: Mechanisms, Epidemiology, and Consequences

See Important Reminder at the end of this policy for important regulatory and legal information.

Fungal and Viral Infections

Coccidioidomycosis, aka Valley Fever

Invasive Pulmonary Aspergillosis in

California digging. Task 1 Interpret the chest radiograph. L. Hendriks

1. Pre-emptive therapy. colonization, colonization, pre-emptive therapy. , ICU colonization. colonization. 2, C. albicans

9/7/2018. Faculty. Overcoming Challenges in the Management of Invasive Fungal Infections. Learning Objectives. Faculty Disclosure

ANTIMYCOTIC DRUGS Modes of Action

Dr Hamed Alzoubi. Fungal infections

Antifungal Agents. Polyenes Azoles Allyl and Benzyl Amines Other antifungals

Diagnostic Procedures for Pulmonary Infiltrates in the Compromised Host

Invasive Fungal Infections

Treatment of Coccidioidomycosis-associated Eosinophilic Pneumonia with Corticosteroids

The sensitivity of fungal microorganisms to fluconazole is as follows:

(Notes on Anti-TB agents are included in the TB syllabus)

Med Chem 401: Mycology ( Mycology

Trends in Invasive Fungal Infection (IFI) in Haematology-Oncology Patients. Saturday, April 18, 2015 Charlottetown, P.E.I.

Updated Guidelines for Management of Candidiasis. Vidya Sankar, DMD, MHS April 6, 2017

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?

An Update in the Management of Candidiasis

Research priorities in medical mycology

Fungi GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA

Title: Author: Speciality / Division: Directorate:

Antifungals in Invasive Fungal Infections: Antifungals in neutropenic patients

number Done by Corrected by Doctor د.حامد الزعبي

Lecture 7: Mycoses Caused by Dimorphic Fungi, Part I

Introduction. Yeast candida, cryptococcus, trichosporon. Filamentous rhizopus, rhizomucor, mucor. Dimorphic Fungi bl t hi t l

Elements for a Public Summary. [Product Name] 40 mg/ml oral suspension. VI.2.1 Overview of disease epidemiology

Challenges and controversies of Invasive fungal Infections

Transcription:

Common Fungi Catherine Diamond MD MPH

Birth Month and Day & Last Four Digits of Your Cell Phone # BEFORE: http://tinyurl.com/kvfy3ts AFTER: http://tinyurl.com/lc4dzwr

Clinically Common Fungi Yeast Mold Dermatophytes Candida Coccidioides Cryptococcus Histoplasma Blastomycosis Aspergillus Mucor Epidermophyton Trichophyton Microsporum

Fungus among Us: A Gross Simplification Serious Immunocompromised, hospitalized e.g. cryptococcal meningitis, pulmonary aspergillus Seen mainly by infectious disease specialists, oncologists, hospitalists, intensivists Increasing Annoying Community dwellers e.g. onychomycosis, vaginal candidiasis Seen mainly by primary care MDs (FP, IM, peds, gyn), dermatologists, podiatrists Always with us

Case One A 32 year old man was diagnosed with AIDS two years ago but did not return for care. He complains of a headache and blurred vision.

C. neoformans found in soil samples from around the world in areas frequented by birds, especially pigeons and chickens, and in association with rotting vegetation

Cryptococcus predominantly presents as meningitis in patients with AIDS, organ transplant or chronic corticosteroids Pulmonary and skin disease also occur Immunocompetent disease rare Presentation

Diagnosis Serum & CSF cryptococcal antigen CSF fungal culture CSF protein, glucose, cell count

Treatment Induction: amphotericin & flucytosine Suppression: oral fluconazole

Complications Increased intracranial pressure which can result in blindness Must check opening pressure! Abnormal defined as >20 cm H20 Immune reconstitution syndrome (IRIS) ART started 2-10 weeks after antifungal Rx initiated

Take Home In AIDS or transplant patient with meningitis, think cryptococcus Check CSF cryptococci antigen, fungal culture & opening pressure Treat cryptococcus with induction amphotericin & flucytosine then suppression fluconazole

Case Two A 42 year old woman with ALL received chemotherapy and become neutropenic. She developed a fever. Chest X-ray shows a right upper lobe cavity.

Presentation Invasive aspergillosis Pulmonary Rhinocerebral (r/o Mucor) Allergic bronchopulmonary aspergillosis(abpa)/sinusitis Chronic pulmonary aspergillosis Skin disease much less common

Diagnosis Culture Galactomannan serum & BAL Galactomannan is a polysaccharide that is a major constituent of Aspergillus cell walls May also be positive with fusarium, histoplama

Treatment Voriconazole Amphotericin Isavuconazole

Mucor vs Aspergillus Both aspergillus & mucor cause rhino orbital cerebral disease in immunocompromised (hematologic malignancies, neutropenic, corticosteroids) Mucor had a predilection for DM Voriconazole will not treat mucor; use amphotericin

Mucor Microbiology Mucor hyphae are broader with irregular branching & rare septation in comparison to aspergillus Rhizopus is a species in the order mucorales Mucor may not grow in culture BD glucan not positive in mucor

Take Home In immunocompromised patient with lung cavity or sinus disease, think aspergillus (or mucor) Check pathology, fungal culture and galactomannan serum and BAL Treat aspergillus with voriconazole and mucor with amphotericin

Case Four A 54 year old male truck driver with no PMH is admitted to the intensive care unit with severe bilateral pneumonia requiring intubation. Sputum cultures and legionella urinary antigen are negative and he is not responding to intravenous ceftriaxone and azithromycin

Coccidomycosis Spherule with Endospores

Presentation Primary Valley Fever (ranges from asymptomatic to severe and may be immunocompetent or immunocompromised) Pneumonia Skin Erythema nododosum Erythema multiforme Pulmonary sequelae Cavities Nodules Disseminated Bone & joint Meningitis Skin

Diagnosis Serology Enzyme Immunoassay screen Confirm and titer with complement fixation or immunodiffusion In contrast to histoplasma, antigen not used (insensitive) Characteristic pathology Cultures may be positive but are a hazard to lab personnel

Treatment Fluconazole Itraconazole for bone/joint Amphotericin

Case Five A 47 year old woman with poorly controlled inflammatory bowel disease is transferred from the colorectal service on piperacillin/tazobactam and TPN because of fever and hypotension.

Presentation Fungemia Line infection Hepatosplenic candidiasis Endophthalmitis Oral thrush Esophagitis Vaginitis

Diagnosis Fungal blood culture (may grow in routine culture as well) KOH stain Visual

Kondo T, Terada K. N Engl J Med 2017;376:1574-1574. Candida Esophagitis

Treatment None (funguria) Skin Nystatin or clotrimazole Thrush Fluconazole Nystatin or clotrimazole Esophagitis Fluconazole Candidemia Micafungin initially Fluconazole (krusei resistant, glabrata dose dependent) Amphotericin (lusitaniae resistant)

Take Home Use micafungin for empiric therapy of candidemia

Conclusions Mild fungal infections (tinea, onochomycosis) occur in immunocompromised and immunocompetent but mostly harmless Serious fungal infections (cryptococcus, aspergillus, mucor) tend to occur in immunocompromised hosts Endemic fungi (cocci, histo, blasto) and candida occur in immunocompromised and immunocompetent and vary in severity

Birth Month and Day & Last Four Digits of Your Cell Phone # BEFORE: http://tinyurl.com/kvfy3ts AFTER: http://tinyurl.com/lc4dzwr